SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-165874
Filing Date
2017-05-10
Accepted
2017-05-10 16:12:24
Documents
8
Effectiveness Date
2017-05-10

Document Format Files

Seq Description Document Type Size
1 S-8 d393741ds8.htm S-8 77150
2 EX-5.1 d393741dex51.htm EX-5.1 7034
3 EX-23.2 d393741dex232.htm EX-23.2 1556
4 EX-99.1 d393741dex991.htm EX-99.1 57467
5 EX-99.2 d393741dex992.htm EX-99.2 50551
6 GRAPHIC g393741g44l22.jpg GRAPHIC 34189
7 GRAPHIC g393741g46r25.jpg GRAPHIC 23454
8 GRAPHIC g393741g47x63.jpg GRAPHIC 5029
  Complete submission text file 0001193125-17-165874.txt   281683
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-217846 | Film No.: 17830363
SIC: 2834 Pharmaceutical Preparations